What is MNKD's P/E ratio?

MANNKIND CORP (MNKD) currently trades at a P/E ratio of 125.68.

MANNKIND CORP reports a Return on Equity (ROE) of 40.40%.

What is MNKD's dividend yield?

MANNKIND CORP offers a dividend yield of 0.00%.

What is MNKD's Deepscope Quality Score?

Deepscope rates MNKD's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy MNKD?

Deepscope's AI Timing Score for MNKD is 62 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does MNKD belong to?

MANNKIND CORP is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

MNKD (NASDAQ) 株価分析 | MANNKIND CORP

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

MNKD

MANNKIND CORP

US:NASDAQ STOCK Healthcare >> Biotechnology News 89

USD 3.40

-0.12 (-3.41%) Day Change

Watchlist Portfolio Compare Chart

125.68

P/E

-5.60

D/E

40.4%

ROE

-3.2%

ROA

0.00%

Div Yield

-0.78

PEG

MANNKIND CORP
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 3.40 Price -0.12 (-3.41%) Day Change	NEWS SCORE: 89

MNKD, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/Eが高い。割高銘柄。
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	89
Magic Formula Rank by ROA	3069
Magic Formula Rank by ROE	3069
Magic Formula Rank by ROIC	3029
Price	3.40
PBV / Sector	-18.37 / 4.63
Earning Per Share	-0.07

PE / Sector	125.68 / 17.43
PEG or PE/Growth / Sector	-0.78 / 0.53
Average 1M Daily Value	19.65 M GREAT
Average 1W Daily Value	17.40 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-6.63 / 449.48
NPM Average (%) / Sector	-17.78 / -1,506.49
NPM Change Average (%) / Sector	-232.83 / 4,940.99
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-3.21 / 30.58
ROA Average (%) / Sector	-5.52 / -347.17
ROA Change Average (%) / Sector	-273.46 / 5,125.52
ROE (%) / Sector	40.40 / -3.58 GREAT
ROE Average (%) / Sector	6.73 / 40.65
ROE Change Average (%) / Sector	-356.65 / 2,109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

登録情報

Analyze Date	2026-06-06 09:09:03
Symbol	MNKD
Name	MANNKIND CORP
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	308.95 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,087.50 / 8,857.28

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 1 Casper Street, Danbury, CT, United States, 06810

Phone: 818 661 5000

Website: https://mannkindcorp.com

Employees: 591

Sector: Healthcare >> Biotechnology

Description: MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve glycemic control in adults with diabetes; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. Its products also include Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; FUROSCIX, a furosemide injection to treat fluid buildup in patients with chronic heart failure or chronic kidney disease. The company's pipeline of treatments for orphan lung diseases include MNKD-201, a dry-powder formulation of nintedanib for the treatment of idiopathic pulmonary fibrosis and MNKD-701. It has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.